Sodium-dependent nucleoside transport in mouse leukemia L1210 cells.
Nucleoside permeation in L1210/AM cells is mediated by (a) equilibrative (facilitated diffusion) transporters of two types and by (b) a concentrative Na(+)-dependent transport system of low sensitivity to nitrobenzylthioinosine and dipyridamole, classical inhibitors of equilibrative nucleoside transport. In medium containing 10 microM dipyridamole and 20 microM adenosine, the equilibrative nucleoside transport systems of L1210/AM cells were substantially inhibited and the unimpaired activity of the Na(+)-dependent nucleoside transport system resulted in the cellular accumulation of free adenosine to 86 microM in 5 min, a concentration three times greater than the steady-state levels of adenosine achieved without dipyridamole. Uphill adenosine transport was not observed when extracellular Na+ was replaced by Li+, K+, Cs+, or N-methyl-D-glucammonium ions, or after treatment of the cells with nystatin, a Na+ ionophore. These findings show that concentrative nucleoside transport activity in L1210/AM cells required an inward transmembrane Na+ gradient. Treatment of cells in sodium medium with 2 mM furosemide in the absence or presence of 2 mM ouabain inhibited Na(+)-dependent adenosine transport by 50 and 75%, respectively. However, because treatment of cells with either agent in Na(+)-free medium decreased adenosine transport by only 25%, part of this inhibition may be secondary to the effects of furosemide and ouabain on the ionic content of the cells. Substitution of extracellular Cl- by SO4(-2) or SCN- had no effect on the concentrative influx of adenosine.
Dagnino
L
L
Cancer Research Group (McEachern Laboratory), University of Alberta, Edmonton, Canada.
Bennett
L L
LL
Paterson
A R
AR
D000241:Adenosine / Q000378:metabolism; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D005573:Formycins / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D009705:Nucleosides / Q000378:metabolism*; D009761:Nystatin / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism*; D013868:Thioinosine / Q000031:analogs & derivatives / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D005573:Formycins; D009705:Nucleosides; C034561:formycin B; D009761:Nystatin; D013868:Thioinosine; D005665:Furosemide; D012964:Sodium; C001789:4-nitrobenzylthioinosine; D000241:Adenosine